GPS Wealth Strategies Group’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

GPS Wealth Strategies Group’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-38	Closed	-$15	–	1329
2023 Q3	$15	Hold	38	–	–	﹤0.01%	1275
2023 Q2	$27	Buy	+38	New	+$245	﹤0.01%	1234

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

GPS Wealth Strategies Group's BLPH Position: Q4 2023 in Review

GPS Wealth Strategies Group sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 38 shares — an estimated $15 sold.

GPS Wealth Strategies Group first reported a position in BLPH in Q2 2023 and held it in 2 quarters. The position peaked at $27 in Q2 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

GPS Wealth Strategies Group reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
GPS Wealth Strategies Group sold 38 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $15.
GPS Wealth Strategies Group first reported a position in Bellerophon Therapeutics, Inc. in Q2 2023 and held it in 2 quarters.
GPS Wealth Strategies Group's Bellerophon Therapeutics, Inc. position peaked at $27 in Q2 2023.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2023, filed 12 Jan 2024.